APA

Balaña C., Capellades J., Pineda E., Estival A., Puig J., Domenech S., Verger E., Pujol T., Martinez-García M., Oleaga L., Velarde J., Mesia C., Fuentes R., Marruecos J., Del Barco S., Villà S., Carrato C., Gallego O., Gil-Gil M., Craven-Bartle J. & Alameda F. (20180129). Pseudoprogression as an adverse event of glioblastoma therapy. : Cancer medicine.

Chicago

Balaña Carmen, Capellades Jaume, Pineda Estela, Estival Anna, Puig Josep, Domenech Sira, Verger Eugenia, Pujol Teresa, Martinez-García Maria, Oleaga Laura, Velarde JoseMaria, Mesia Carlos, Fuentes Rafael, Marruecos Jordi, Del Barco Sonia, Villà Salvador, Carrato Cristina, Gallego Oscar, Gil-Gil Miguel, Craven-Bartle Jordi and Alameda Francesc. 20180129. Pseudoprogression as an adverse event of glioblastoma therapy. : Cancer medicine.

Harvard

Balaña C., Capellades J., Pineda E., Estival A., Puig J., Domenech S., Verger E., Pujol T., Martinez-García M., Oleaga L., Velarde J., Mesia C., Fuentes R., Marruecos J., Del Barco S., Villà S., Carrato C., Gallego O., Gil-Gil M., Craven-Bartle J. and Alameda F. (20180129). Pseudoprogression as an adverse event of glioblastoma therapy. : Cancer medicine.

MLA

Balaña Carmen, Capellades Jaume, Pineda Estela, Estival Anna, Puig Josep, Domenech Sira, Verger Eugenia, Pujol Teresa, Martinez-García Maria, Oleaga Laura, Velarde JoseMaria, Mesia Carlos, Fuentes Rafael, Marruecos Jordi, Del Barco Sonia, Villà Salvador, Carrato Cristina, Gallego Oscar, Gil-Gil Miguel, Craven-Bartle Jordi and Alameda Francesc. Pseudoprogression as an adverse event of glioblastoma therapy. : Cancer medicine. 20180129.